Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.